Daniel Greer, PharmD, BCPP, clinical assistant professor, Rutgers Ernest Mario School of Pharmacy, speaks on at-risk populations of chronic insomnia, and the reciprocal relationship between the condition and other comorbidities.
Elderly people and women are notable at-risk populations for chronic insomnia, which has been shown to share a reciprocal relationship with several other health conditions, said Daniel Greer, PharmD, BCPP, clinical assistant professor, Rutgers Ernest Mario School of Pharmacy.
Transcript
Can you speak on at-risk populations for chronic insomnia?
Sleep has a reciprocal relationship with so many disease states. If you are depressed, you probably have issues with sleep, whether that be sleeping too little or sleeping too much. Or it could be the other way, that maybe your issues with sleep made you more predisposed and led to your depressive illness.
It's not just mental illnesses, it's medical conditions as well. So, people who sleep less have a higher likelihood of getting infections, colds, and getting sick in that way. Also, people who are sick and have colds and infections don't sleep as well. So, then they aren't able to rebuild their immune system and rebuild that functioning.
Same goes for a lot of things–pain as well. People who have pain don't sleep as well, and then people who don't sleep as well are more sensitive to pain. So, the impact of insomnia is kind of like a snowball, whether it starts young or whether it starts in adulthood, there's these issues that keep growing.
For any at-risk populations, the biggest at-risk population is the elderly. The older and older you get, the more likelihood that you're going to have chronic insomnia. So, generally young people have less insomnia than elderly people. Next, women have a higher likelihood of insomnia and another at-risk population is just genetics.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More